pioglitazone has been researched along with Dry Eye in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Excerpt | Relevance | Reference |
---|---|---|
"Dry eye was induced in 6-week-old female C57 mice." | 1.40 | Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice. ( Chen, Y; Li, B; Li, M; Sheng, M; Wang, W; Yang, L; Zhang, X, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y | 1 |
Zhang, X | 1 |
Yang, L | 1 |
Li, M | 1 |
Li, B | 1 |
Wang, W | 1 |
Sheng, M | 1 |
1 other study available for pioglitazone and Dry Eye
Article | Year |
---|---|
Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
Topics: Animals; Cell Count; Conjunctiva; Disease Models, Animal; Dry Eye Syndromes; Female; Gene Expression | 2014 |